The organization will work with health system partners to develop innovative practices to increase screening and reduce cancer disparities
Posted: October 19, 2021, 3:47 p.m. EDT|Update: 46 minutes ago
INDIANAPOLIS, October 19, 2021 / PRNewswire / – The American Cancer Society (ACS) announced a partnership with HealthLinc to improve colorectal cancer screening rates as part of the National Return to Screening (RTS) initiative. This is part of a global cohort with more than 51 facilities across the country to drive quality improvement processes and interventions to provide cancer screenings in an appropriate, safe and equitable manner during the COVID-19 pandemic. and beyond. This specific intervention was made possible thanks to the charitable support of Roche Diagnostics.
“Roche’s support for our return-to-screening effort with HealthLinc is essential to address the gaps and significant delays in cancer screening that we have seen in the wake of the pandemic,” said Kathy goss, Ph.D., regional vice president of cancer control at the American Cancer Society. “Ultimately our goal is to save more lives by preventing cancer and detecting cancers earlier when they are easier to treat.”
At the onset of the COVID-19 pandemic, elective medical procedures, including cancer screening, were largely suspended to prioritize urgent needs and reduce the risk of the spread of COVID-19 in healthcare facilities. One consequence of this has been an immediate and substantial drop in cancer screening. In response, ACS launched an RTS initiative to support public health agencies, healthcare providers and screening advocates across the country to promote and deliver cancer screening in an appropriate, safe and equitable manner during the COVID-19 pandemic. Additional thanks to Genentech, Roche Group Member, Pfizer Oncology and Merck (known as MSD outside United States and Canada) as well as other partners for their national sponsorship and campaign support.
“Roche is proud to support this national effort with the American Cancer Society to address screening delays and get people back on track with their preventive health,” said Matt Sause, President and CEO, Roche Diagnostics Corporation North America. âOur long-term vision is to continue to innovate in diagnostics and therapies with the goal of one day finding a cure for cancer, a disease that affects so many people. “
As part of the national initiative, ACS is partnering with health systems to implement targeted efforts to screen people who have historically had low testing rates and are most affected by COVID-19. These return-to-screening quality improvement projects will help health systems apply quality improvement tools and evidence-based interventions in underfunded communities to minimize the effects of the pandemic on cancer screening. As part of this collaboration, the American Cancer Society will award $ 20,000 at HealthLinc, totaling over one million to support the first in a series of cohorts.
“The pandemic has had a disproportionate impact on underserved people in many ways, including the postponement of life-saving preventive screenings,” said Beth wrobel, CEO of HealthLinc. “We are grateful to the American Cancer Society for their support as we work to provide our patients with the cancer screens they desperately need.”
The success of this initiative includes: minimizing the effects of the pandemic on screening for breast, cervical and colorectal cancer; address disparities and reduce barriers to screening exacerbated by the pandemic; create learning communities to promote the sharing of best practices; and the execution of a lasting, lasting and meaningful process.
Ashley noonan, American Cancer Society
About the American Cancer Society
The American Cancer Society is a local, global force of 1.5 million volunteers dedicated to saving lives, celebrating lives, and leading the fight for a world without cancer. From groundbreaking research to free accommodation near treatment, a 24/7/365 live helpline, free rides to treatment, and convening powerful activists to raise awareness and make an impact, the Company is cancer attack from all angles. For more information, visit www.cancer.org
Show original content:
SOURCE American Cancer Society in Indiana
The above press release has been provided courtesy of PRNewswire. The views, opinions and statements contained in the press release are not endorsed by Gray Media Group and do not necessarily state or reflect those of Gray Media Group, Inc.